Adjust Font Sizing:

Clinical Update Webinar: Learn about a new FDA-Approved Treatment Option for Narcolepsy

May 8th, 2023

Please join us on June 1st, 2023 at 5:30 p.m. (ET) for the first Clinical Update Webinar* in our 2023 series this year. In this session, you will learn about this newly FDA-approved extended release sodium oxybate therapy for people with narcolepsy. Dr. Jennifer Gudeman will discuss the science behind this treatment option, the safety precautions and additional resources. As well, she will answer some of the most frequently asked questions that were submitted in advance of this webinar.

Register for the Webinar

Do you want to submit questions?

Last call for advance questions due on May 9, 2023*

**Please note your contact information will not be shared with employees of this company. 

About the presenter

Dr. Jennifer Gudeman, is Senior Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals. Jennifer joined Avadel in 2020 and has been in the pharmaceutical industry for more than 20 years. During her career, she has led or contributed to six commercial launches and three clinical development programs. She graduated summa cum laude with a bachelor’s degree in pharmacy and magna cum laude with a doctorate in pharmacy from the University of Health Sciences and Pharmacy in St. Louis, Missouri. 

# # #
Date Created: May 8th, 2023
Last Updated: May 8th, 2023